Main Outcome |
|
HbA1c>7% vs.<7% (Overall) |
1.63 (1.05–2.54) |
Female |
4.83 (1.84–12.71) |
Male |
1.02 (0.60–1.71) |
Demographic Conditions |
|
Age (>65 years vs. <65 years) |
1.30 (0.86–1.97) |
Race/ethnic group (minority vs. white) |
1.22 (0.80–1.87) |
Gender (male vs. female) |
1.22 (0.80–1.86) |
Health insurance (none or self-pay vs. insured) |
1.07 (0.67–1.73) |
Caregiving (paid or informal caregiver vs. none) |
1.29 (0.86–1.93) |
Comorbid Conditions |
|
Insulin-dependent diabetes (yes vs. no) |
1.21 (0.81–1.81) |
Prior/Current MI (yes vs. no) |
1.32 (0.88–1.98) |
Prior/Current CHF (yes vs. no) |
1.64 (1.09–2.48) |
Prior/Current stroke (yes vs. no) |
0.92 (0.50–1.66) |
Prior/Current moderate to severe renal disease (yes vs. no) |
1.37 (0.90–2.08) |
Prior/Current COPD (yes vs. no) |
1.49 (0.76–2.95) |
Prior/Current PVD (yes vs. no) |
1.06 (0.63–1.78) |
Smoking status (current vs. prior or never) |
1.05 (0.51–2.19) |
Dyslipidemia history (yes vs. no) |
0.90 (0.58–1.38) |
Ghali Comorbidity Index >1 (yes vs. no) |
1.61 (1.05–2.46) |
Had cardiac surgery during admission (yes vs. no) |
0.79 (0.43–1.46) |
Prescribed medications on discharge |
|
Statin (yes vs. no) |
1.19 (0.69–2.05) |
ACE-I/ARB (yes vs. no) |
1.25 (0.83–1.88) |
Beta-blocker (yes vs. no) |
0.85 (0.53–1.36) |
Antiplatelet (yes vs. no) |
1.52 (0.79–2.93) |
New insulin (yes vs. no) |
0.72 (0.34–1.54) |